Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HRMY | AMGN | BMY | VRTX | GILD |
| Company | Harmony Biosciences Holdings Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 32.85 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 33.01 | 289.84 | 58.31 | 455.43 | 89.58 |
| Low | 32.33 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 32.99 | 289.92 | 58.38 | 450.52 | 89.87 |
| Change | +0.20 | +2.05 | +0.50 | -0.71 | +1.24 |
| % Change | +0.61% | +0.71% | +0.86% | -0.16% | +1.40% |
| Volume | 58,419 | 996,397 | 2,629,571 | 554,545 | 1,299,016 |
| 20-Day Average Volume | 1,222,284 | 2,789,642 | 12,145,988 | 1,294,470 | 7,385,089 |
| Previous Close | 32.79 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 34.23 | 307.32 | 55.91 | 479.05 | 90.86 |
| 20-Day Raw Stochastic | 16.71% | 23.65% | 66.77% | 1.99% | 23.60% |
| 20-Day Relative Strength | 44.51% | 34.98% | 60.20% | 39.88% | 52.14% |
| Weighted Alpha | +7.97 | +1.01 | +25.37 | +16.68 | +24.80 |
| Today's Opinion | 24% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 24% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 24% Buy | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.64% since 11/14/24 | -2.67% since 11/14/24 | -0.85% since 11/14/24 | -7.72% since 11/14/24 | -3.26% since 11/14/24 |
| Low | 32.33 on 11/21/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 33.66 on 11/20/24 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | -6.18% since 10/21/24 | -9.07% since 10/21/24 | +11.28% since 10/21/24 | -6.58% since 10/21/24 | +3.26% since 10/21/24 |
| Low | 31.02 on 10/31/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 41.61 on 10/29/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -10.90% since 08/21/24 | -12.50% since 08/21/24 | +19.74% since 08/21/24 | -8.12% since 08/21/24 | +18.60% since 08/21/24 |
| Low | 31.02 on 10/31/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 41.61 on 10/29/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +10.59% since 05/21/24 | -8.52% since 05/21/24 | +37.21% since 05/21/24 | +1.05% since 05/21/24 | +32.42% since 05/21/24 |
| Low | 28.57 on 06/20/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 41.61 on 10/29/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,870,046 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 57,031 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 582,020,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | 128,850,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 186,040,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | 46,090,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.77 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.79 on 10/29/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 10/29/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 15.39 | 14.57 | 49.77 | 0.00 | 19.81 |